Literature DB >> 11131888

Effect of simulated gastric fluid and bile on survival of Vibrio vulnificus and Vibrio vulnificus phage.

J Koo1, A DePaola, D L Marshall.   

Abstract

Bacteria and phages may be exposed to acid conditions in the stomach and to bile in the intestine. Survival of three strains of Vibrio vulnificus and three strains of its phages was examined at 37 degrees C after exposure to simulated gastric fluid at pH 3 to 4 or to 0, 1, and 2% bile in broth or buffer. Mean D-values (decimal reduction times) at pH 4 and 3 were 3.3 and 1.3 min for V. vulnificus and 97.8 and 0.7 min for its phages. No V. vulnificus survivors were found at pH 2.0. There were few survival differences among strains of V. vulnificus or its phages. Numbers of V. vulnificus increased 1 log in tryptic soy broth containing 1 or 2% bile after 3 h. Numbers of V. vulnificus and its phages remained constant in phosphate-buffered saline regardless of bile concentrations up to 3 h. Those V. vulnificus bacteria and phages that survive stomach acidity may proliferate in the small intestine, since they are resistant to bile.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11131888     DOI: 10.4315/0362-028x-63.12.1665

Source DB:  PubMed          Journal:  J Food Prot        ISSN: 0362-028X            Impact factor:   2.077


  11 in total

Review 1.  Vibrio vulnificus: disease and pathogenesis.

Authors:  Melissa K Jones; James D Oliver
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

2.  Microencapsulation of bacteriophage felix O1 into chitosan-alginate microspheres for oral delivery.

Authors:  Yongsheng Ma; Jennifer C Pacan; Qi Wang; Yongping Xu; Xiaoqing Huang; Anton Korenevsky; Parviz M Sabour
Journal:  Appl Environ Microbiol       Date:  2008-05-30       Impact factor: 4.792

3.  Microencapsulation of phages to analyze their demeanor in physiological conditions.

Authors:  Esra Acar Soykut; Emine Kübra Tayyarcan; Şefika Evran; İsmail Hakkı Boyacı; İbrahim Çakır; Maha Khaaladi; Sami Fattouch
Journal:  Folia Microbiol (Praha)       Date:  2019-02-12       Impact factor: 2.099

4.  Antacid increases survival of Vibrio vulnificus and Vibrio vulnificus phage in a gastrointestinal model.

Authors:  J Koo; D L Marshall; A DePaola
Journal:  Appl Environ Microbiol       Date:  2001-07       Impact factor: 4.792

5.  Inactivation of Escherichia coli O157:H7 in simulated human gastric fluid.

Authors:  Mark L Tamplin
Journal:  Appl Environ Microbiol       Date:  2005-01       Impact factor: 4.792

6.  Genetically manipulated phages with improved pH resistance for oral administration in veterinary medicine.

Authors:  Franklin L Nobrega; Ana Rita Costa; José F Santos; Melvin F Siliakus; Jan W M van Lent; Servé W M Kengen; Joana Azeredo; Leon D Kluskens
Journal:  Sci Rep       Date:  2016-12-15       Impact factor: 4.379

Review 7.  Semi-Solid and Solid Dosage Forms for the Delivery of Phage Therapy to Epithelia.

Authors:  Teagan L Brown; Steve Petrovski; Hiu Tat Chan; Michael J Angove; Joseph Tucci
Journal:  Pharmaceuticals (Basel)       Date:  2018-02-26

8.  A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota.

Authors:  Tomasz Cieplak; Nitzan Soffer; Alexander Sulakvelidze; Dennis Sandris Nielsen
Journal:  Gut Microbes       Date:  2018-08-24

Review 9.  Rethinking the bile acid/gut microbiome axis in cancer.

Authors:  John P Phelan; F Jerry Reen; Jose A Caparros-Martin; Rosemary O'Connor; Fergal O'Gara
Journal:  Oncotarget       Date:  2017-12-01

Review 10.  In Vitro Characteristics of Phages to Guide 'Real Life' Phage Therapy Suitability.

Authors:  Eoghan Casey; Douwe van Sinderen; Jennifer Mahony
Journal:  Viruses       Date:  2018-03-30       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.